These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9762878)

  • 21. Sentinel lymph node biopsy in thick malignant melanoma: A 16-year single unit experience.
    Hunger RE; Michel A; Seyed Jafari SM; Shafighi M
    Eur J Dermatol; 2015; 25(5):472-6. PubMed ID: 26394835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
    Reintgen DS; Cox C; Slingluff CL; Seigler HF
    Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic factors and improving treatment of cutaneous melanoma].
    Vihinen P; Kähäri VM; Pyrhönen S
    Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary cutaneous melanoma. Prognostic classification of anatomic location.
    Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2492-8. PubMed ID: 7736393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic factors of localized malignant melanoma: study of 639 patients].
    Nagore Enguídanos E; Oliver Martínez V; Botella Estrada R; Insa Mollá A; Fortea Baixauli JM
    Med Clin (Barc); 2005 Mar; 124(10):361-7. PubMed ID: 15766505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Am Acad Dermatol; 2015 Jan; 72(1):71-7. PubMed ID: 25455840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
    Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
    Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphovascular invasion as a prognostic factor in melanoma.
    Egger ME; Gilbert JE; Burton AL; McMasters KM; Callender GG; Quillo AR; Brown RE; St Hill CR; Hagendoorn L; Martin RC; Stromberg AJ; Scoggins CR
    Am Surg; 2011 Aug; 77(8):992-7. PubMed ID: 21944512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plantar malignant melanoma in a white Caucasian population.
    Dwyer PK; Mackie RM; Watt DC; Aitchison TC
    Br J Dermatol; 1993 Feb; 128(2):115-20. PubMed ID: 8457443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant melanoma in pregnancy. A population-based evaluation.
    O'Meara AT; Cress R; Xing G; Danielsen B; Smith LH
    Cancer; 2005 Mar; 103(6):1217-26. PubMed ID: 15712209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incisional biopsy and melanoma prognosis.
    Bong JL; Herd RM; Hunter JA
    J Am Acad Dermatol; 2002 May; 46(5):690-4. PubMed ID: 12004308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in patients with localized primary cutaneous melanoma.
    Mervic L
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):27-31. PubMed ID: 23000937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
    Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
    Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose adjuvant interferon for stage III malignant melanoma.
    Inman JL; Russell GB; Savage P; Levine EA
    Am Surg; 2003 Feb; 69(2):127-30. PubMed ID: 12641352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
    Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
    J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.